Edesa Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Cap	51	18	14	14	15	98
Market Cap Growth	242.20%	22.07%	6.55%	-11.52%	-84.38%	26.45%
Enterprise Value	41.05	16.11	13.43	8.3	8.26	90.38
Last Close Price	5.30	2.47	4.45	4.41	6.44	51.66
Forward PE	-	0.88	0.88	0.88	56.67	-
PB Ratio	26.92	1.42	7.29	1.92	1.63	7.51
P/TBV Ratio	4.90	1.34	-	2.79	2.09	8.42
Debt / Equity Ratio	-	0	0	0.00	0	0.00
Net Debt / Equity Ratio	-0.98	-0.87	-0.51	-0.75	-0.75	-0.59
Net Debt / EBITDA Ratio	1.03	1.39	0.15	0.58	0.39	0.33
Net Debt / FCF Ratio	1.20	1.47	0.21	0.79	0.58	0.57
Asset Turnover	0.01	0	0	0	0	0
Quick Ratio	4.67	10.60	0.71	3.29	3.90	7.64
Current Ratio	4.76	10.67	0.91	3.53	4.25	8.29
Return on Equity (ROE)	-76.93%	-99.57%	-136.66%	-101.88%	-156.34%	-120.39%
Return on Assets (ROA)	-72.17%	-91.24%	-110.44%	-90.14%	-140.45%	-186.87%
Return on Invested Capital (ROIC)	-933.12%	-603.20%	-511.05%	-449.80%	-481.08%	-642.07%
Return on Capital Employed (ROCE)	-80.96%	-109.63%	-155.03%	-111.77%	-162.85%	-211.83%
Buyback Yield / Dilution	-102.57%	-77.54%	-3.97%	-33.61%	-32.28%	-41.52%
Total Shareholder Return	-102.57%	-77.54%	-3.97%	-33.61%	-32.28%	-41.52%

SEC Filings: 10-K · 10-Q